Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics

BACKGROUND: Antiviral resistance among influenza A viruses is associated with high morbidity and mortality in immunocompromised hosts. However, treatment strategies for drug-resistant influenza A are not established. A triple-combination antiviral drug (TCAD) regimen consisting of amantadine (AMT),...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Seo, Sachiko, Englund, Janet A, Nguyen, Jack T, Pukrittayakamee, Sasithon, Lindegardh, Niklas, Tarning, Joel, Tambyah, Paul A, Renaud, Christian, Went, Gregory T, de Jong, Menno D, Boeckh, Michael J
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2012
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3912210/
https://ncbi.nlm.nih.gov/pubmed/23264438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP2475
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia